Shares of Relx Plc (NYSE:RELX – Get Free Report) have received a consensus recommendation of “Buy” from the eight brokerages that are presently covering the firm, Marketbeat.com reports. Two equities research analysts have rated the stock with a hold rating, four have assigned a buy rating and two have given a strong buy rating to the company.
RELX has been the subject of several analyst reports. Wall Street Zen raised shares of Relx from a “hold” rating to a “buy” rating in a research note on Saturday. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Relx in a research report on Monday, December 29th. Morgan Stanley reaffirmed an “overweight” rating on shares of Relx in a research report on Monday, February 2nd. Zacks Research upgraded Relx from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, January 6th. Finally, Deutsche Bank Aktiengesellschaft upgraded shares of Relx from a “hold” rating to a “buy” rating in a research report on Tuesday, December 9th.
View Our Latest Research Report on RELX
Hedge Funds Weigh In On Relx
Relx Price Performance
Shares of RELX opened at $29.31 on Wednesday. The stock has a 50 day simple moving average of $39.16 and a 200 day simple moving average of $43.45. The company has a current ratio of 0.47, a quick ratio of 0.42 and a debt-to-equity ratio of 2.55. Relx has a 52-week low of $29.09 and a 52-week high of $56.33.
About Relx
RELX plc is a global provider of information, analytics and decision tools for professional and business customers. The company supplies content, data and analytical services that support decision-making across scientific, technical and medical research, legal and regulatory practice, and risk and business analytics. RELX’s offerings are largely delivered via digital platforms and subscription services designed for institutions, corporations and professionals who require specialized, high-value information and workflow solutions.
RELX operates through distinct business lines that include Elsevier, which provides scientific, technical and medical journals, books and online platforms such as research and discovery tools; Legal and Professional services, which deliver legal, regulatory and compliance content and workflow solutions; Risk & Business Analytics, which offers data, analytics and decision tools for insurance, banking, corporate and government risk assessment; and Exhibitions, which organizes industry trade shows and events.
Featured Articles
- Five stocks we like better than Relx
- Nvidia CEO Issues Bold Tesla Call
- Your Bank Account Is No Longer Safe
- Buy this Gold Stock Before May 2026
- The day the gold market broke
- What a Former CIA Agent Knows About the Coming Collapse
Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.
